Figure 3.
Pharmacophore-directed chemical modifications of gracillin A leading to novel compounds with distinct pharmacodynamic profiles by selective CypA vs. CypD inhibition [126].
Pharmacophore-directed chemical modifications of gracillin A leading to novel compounds with distinct pharmacodynamic profiles by selective CypA vs. CypD inhibition [126].